Veru Inc. (VERU)
NASDAQ: VERU · Real-Time Price · USD
2.170
-0.230 (-9.58%)
Dec 29, 2025, 1:49 PM EST - Market open
Veru Inc. Employees
Veru Inc. had 20 employees as of September 30, 2025. The number of employees decreased by 190 or -90.48% compared to the previous year.
Employees
20
Change (1Y)
-190
Growth (1Y)
-90.48%
Revenue / Employee
n/a
Profits / Employee
-$1,136,314
Market Cap
34.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 20 | -190 | -90.48% |
| Sep 30, 2024 | 210 | 21 | 11.11% |
| Sep 30, 2023 | 189 | -44 | -18.88% |
| Sep 30, 2022 | 233 | -19 | -7.54% |
| Sep 30, 2021 | 252 | -87 | -25.66% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VERU News
- 12 days ago - Veru Inc. (VERU) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress - GlobeNewsWire
- 19 days ago - Veru to Report Fiscal Year 2025 Financial Results on December 17th - GlobeNewsWire
- 2 months ago - Veru to Present Two Abstracts at ObesityWeek 2025 - GlobeNewsWire
- 2 months ago - Veru Announces Proposed Public Offering - GlobeNewsWire
- 3 months ago - Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity - GlobeNewsWire
- 4 months ago - Veru Inc. (VERU) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress - GlobeNewsWire